of intravenously administered Gd-L1 and ProHance were assessed by
ICP-MS quantification of the Gd content in plasma. For this purpose,
after the intravenous injection of 0.15 mmol/kg of Gd-L1 or ProHance
to healthy mice (n = 3), blood was collected from
mice tail veins at variable time points (t = 5 min,
10 min, 15 min, 30 min, 1 h, and 4 h). Before ICP-MS analysis, blood
samples were digested with concentrated HNO3 (70%) under
microwave heating (Milestone MicroSYNTH Microwave laboratory station,
Balgach, Switzerland, equipped with an optical fiber temperature control
and HPR-1000/6 M high-pressure reactor, Milestone, Bergamo, Italy).
After the digestion, 3 mL of ultrapure water was added to each sample.
The specimens were then subjected to ICP-MS analysis (Element-2; Thermo-Finnigan,
Rodano (MI), Italy) to measure the concentration of Gd with respect
to standard curves. Results were reported as the Gd micromolar concentration
as a function of collection time.